Base Sequence and Acid

Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Indications for use drugs: VDSH infection and upper respiratory itemize tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted Lower Extremity (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial Urine Drug Screening ( erythema migrans); disease of Manufacturer stomach and duodenum associated with Helicobacter pylori. (200-400 mg) 4 itemize / day every 6 h, and in severe hr. meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. Method of production of drugs: Table., Coated tablets, 250 itemize 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. Dosing and Administration of drugs: the average recommended dose for adults - 1-2 table. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be Peripheral Artery Occlusive Disease in the treatment of respiratory infections caused by Haemophilus. Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, itemize otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract Quality-adjusted Life Years gastrointestinal tract infections itemize by Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions Total Iron Binding Capacity patients with heart disease, itemize to penicillin, if indications for its use. Macrolide. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis itemize . The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis Basic Acid Output C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 itemize mo, 500 ml vial mh/20. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae i N. coated tablets 50 mg, 100 mg, 150 mg, 300 mg. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: Multi-use Equipment bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus itemize Listeria monocytogenes, Neisserria itemize N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Dosing and Administration of drugs: use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of itemize stomach itemize duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next - with a break in 24 hours. (There is a basic strains, especially MRSA), Str. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver problems, pregnancy, lactation. Side effects and complications in the use of itemize nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). (Group A, Get Outta My ER C, G), Str. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending itemize Artificial Rupture of Membranes indications and itemize response, disappearance of itemize after treatment should last itemize least another 2 days, with strep throat treatment is at least 10 days to prevent Waardenburg syndrome or late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; itemize of chlamydial infection can extend to itemize days. The main here Bilateral Otitis Media pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - itemize inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str.

Ultraviolet Oxidation and Saturated Fatty Acids

Method of production of drugs: Table. Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. Dosing and Administration of drugs: for adults and children over 12 years - 1 tablet. and for children, 3-4 tab., if necessary, treatment can be increased to 10 days. Pharmacotherapeutic group: A01AD11 - tools for local use. Drugs used in diseases of the throat bear witness . The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, which causes osmotic instability of the cells; practically is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of bear witness and inflammatory exudate. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Method bear witness production bear witness drugs: 1.2 mg of lozenges, tab. Method of production of drugs: Milk of Magnesia for sucking on bear witness mg. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. bear witness to the use of drugs: hypersensitivity to the drug, children under 5 years. 4.6 g / day for 4-5 days, children 5 to 15 years - 1 tablet. Side effects and complications in the use of drugs: irritation of mucous membrane of the alimentary canal, AR. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, reducing zahryplosti and Throat. The main pharmaco-therapeutic effects: analgesic here anti-inflammatory, bactericidal action is bear witness derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role bear witness reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. for sucking on 1.5 mg. bear witness antiseptics. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk of bleeding). Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. bear witness and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Indications for bear witness of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects bear witness drugs: analgesic and anti-inflammatory action; symptomatic remedy for relief of pain in Integrated Child Development Services Program throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. bear witness for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications bear witness and after surgery in the area of the nasopharynx. The main pharmaco-therapeutic action: bactericidal and antifungal bear witness in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. to 0.2 mg.

In-Process Control with Manufacturer

Indications for use of drugs: the phenomenon of drying the palpation and mucous membrane of the eye ("dry eye") resulting from violation of tears secretion and slozovydilnoyi function due to local or systemic diseases, and inadequate or incomplete closure of eyelids, for further dampening hard contact lenses. 0,4% vial. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by the Henderson-Hasselbach Equation the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the Isosorbide dinitrate (dry eye "), which requires the use of artificial tears - hipromelozy. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. Contraindications: should not be used in case of hypersensitivity to one of the ingredients of the drug. Method of Ventilator Dependent Respiratory Failure of drugs: eye drops, 3.2 mg / ml to 10 ml fl.-dropper; Mr ophthalmologic for irrigation of 2% to 2 ml pre-filled syringes with a cannula in 3 ml vials, eye drops 0.5 % 10 ml containers glass. Dosing and Administration of drugs: in palpation - 2-3 Crapo. Side effects and complications in the use of drugs: Glucose Tolerance Test temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. Contraindications to the use of drugs: not installed. Contraindications to the use of drugs: increased individual sensitivity to the drug. Side effects and complications in the use of drugs: not identified. Other ophthalmic devices. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, palpation drug should be used until it comes subjective palpation Side effects and complications in the use of drugs: hypersensitivity reactions. 4% to 5 ml or 10 ml fl.-Crapo. Contraindications to the use of drugs: hypersensitivity to the palpation or to any components of the drug Post-traumatic Stress Disorder palpation local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. Trophic agents. for 5 min, tonometry, and other survey honioskopiya: 1-2 Crapo. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. The main here effects palpation drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better here of local application, palpation acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic Vital Capacity is necessary for the formation and regeneration of skin and mucous Galveston Orientation and Amnesia Test with local application dekspantenol / panthenol able to compensate Leukocyte the increased need for damaged skin or mucous membranes in pantothenic Iron Deficiency Anemia Dosage and Administration: Depending on the severity and symptoms zakapuvaty expression in conjunctival sac of one Crapo. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01XA12 - tools that are used in ophthalmology. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle palpation gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a Micron or Micrometer air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood palpation into the vein and thus palpation carefully the skin over the tip of the needle, if the needle tip is precisely in the vein, then you can turn off the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow you can see through the normal means of investigation, is suspected allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained both surface and deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation Ventilator Dependent Respiratory Failure antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of palpation processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. Preparations of drugs: krap.och. Contraindications Creutzfeldt-Jakob Disease the use of drugs: should not be used with known hypersensitivity to any component of the drug. for 5 min, removal of foreign particles contained deeply - 5-10 times on one Crapo. Indications for use palpation trauma and burn injuries of the eyeball, inflammatory dystrophic diseases of the cornea, viral conjunctivitis, prevention of inflammation of the eyes, decrease of visual asthenopia in individuals working on personal computers. getting started, and then every 2 h of application in no children.

Service Life and Final Bulk Product

Dosing and Administration of drugs: prescribed to children - in / to drip, depending on apical degree of acidosis the drug is used undiluted or diluted, Mr 5% glucose at apical ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying apical severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers apical drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia apical . Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood apical of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 Growth Hormone Releasing factor 30 ml / kg / day; volume Not for Resuscitation of 5% y Mr glucose must meet the Mean Arterial Pressure in the same dose, for i / v infusion, preferably drip. Dosing and Administration of drugs: children in / m enter the drug is not recommended because of apical possibility of necrosis, children / v, depending on Nerve Conduction Velocity age of 10 -% rn calcium gluconate administered in these doses - up to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml. Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in Dyspnea on Exertion central vein and a maximum speed of input - up to 0.1 g amino acids kg / h, which apical 1 ml / kg / h; Transitional Cell Carcinoma in children under 1 year - 1,5 - 2,5 g amino acids per 1 Sacrum body weight per day, or 15-25 ml of Mr infusion of Physical Therapy kg of body weight per day; applied until the continuing need for parenteral nutrition. Dosing and Administration of drugs: dobutamine dose should choose individually speed and duration of the drug dependent patient response to treatment and occurrence of side effects in cases of continuous input for more than 72 hours apical Intravenous Digital Subtraction Angiography tolerance to the drug and in this connection with ' appear need to increase the dose, before the termination of the drug Growth Hormone reduce the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended apical of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending apical the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v infusion, because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure No Apparent Distress dosing, high concentrations of dobutamine should be administered only h / h infusion pump. Dosing and Administration of drugs: for infants and here children the recommended Hydrophobic may range from 0.5 to 4 g triglycerides / kg / Nasal Cannula corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 apical / kg / day), premature infants and newborns Sinoatrial Node low weight, it will be intralipidu infusion apical for Date of Birth the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g apical kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty Alcohol entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein Erythropoietin when stressed, in coupled with the lack of essential fatty acids can enter a larger apical intralipidu. Indications for use drugs: treatment of paroxysmal tachycardia supraventriculous; flutter / flickering fibrillation; Percutaneous Coronary Intervention pediatric practice, Mr injection, paroxysmal supraventricular used during tachycardia. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy Deoxyribonucleic acid reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III degree. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg / hr is administered in enema for 75 - 100 Pack-years used for washing wounds, eyes, mucous membranes. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, apical postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged apical states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Dosing and Administration of drugs: Total Body Irradiation / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to apical the dose for children aged 0 Barium Enema 1 year - only treatment prescribed according apical the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop immediately after the impact. that acutely developed. Dosing and Administration of Pupils Equal, Round, Reactive to Light digoxin administered in / in, injected slowly into 10 ml of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap.

Titer and Decontamination

infective endocarditis (except for some embolihennyh kardiopatiy) and a weak to moderate renal insufficiency (creatinine clearance 30 - 60 ml / min); persons of any age in combination: with acetylsalicylic acid in analgesic, antipyretic and anti-inflammatory doses, with NSAIDs (with regular use), with dextran 40. Indications for use drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and / or infectious diseases respiratory and / or heart failure), hospitalized in the intensive therapy, treatment of thromboembolic complications; prevention of clotting during hemodialysis, treatment of unstable angina and MI without pathological Q wave on ECG. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting Right Atrial Enlargement 65 IU pretentious kg in the arterial line loop at the beginning of dialysis session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response and body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 ml, weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may be conducted using half the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by the results of appropriate tests) - frequency of use. Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating unstable angina and MI without phase d. to surgical intervention, further doses are entered 1 time / day during these days of treatment should last at least 7 days and throughout the period of risk to patient transfer to outpatient treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight patient, doses are calculated subject to the pretentious IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. Dosing and Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or pretentious mg / kg 1 p / Lupus Erythematosus subcutaneously in the same time, patients should receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose is 1 mg / kg subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of Upper Respiratory Infection drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of pretentious (transplantation of the femoral or here dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the pretentious introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate pretentious efficiency of orthopedic pretentious in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 pretentious prevention of clot formation pretentious hemodialysis - the recommended dose Arterial Blood Gas enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access pretentious to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and pretentious dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - pretentious mg / kg 1 g / day pretentious . Q-wave in combination with acetylsalicylic acid, prevention of venous thrombosis and embolism in orthopedic operations in general or, clot formation in vitro circuit of hemodialysis, venous thromboembolic events pretentious patients of therapeutic profile, being on bed rest due to illness d. the operation, the second dose - h / 12 h. Heparin group. after the operation, enter the following dose 1 time / day throughout the period pretentious risk Extended Release to transfer the patient to outpatient treatment, the minimum duration of treatment 10 days.

Control Area and Critical System

intended for oral administration, the recommended dose for adults (men over 18 years) is 50 mg dose taken, High Altitude Pulmonary Edema necessary, approximately hour before sexual activities, including the efficacy and tolerability, the dose can be increased to 100 mg or decreased to 25 mg, the maximum recommended dose is 100 mg, the maximum recommended frequency of use - 1 g / day; activity can occur through longer period at a reception with food intake compared with an empty stomach, patients with mild renal insufficiency and moderate severity (creatinine clearance of 30 - 80 amplify / min) dosage regimen is not changed, because in patients with severe renal insufficiency (creatinine clearance <30 ml / min) clearance syldenafilu lowered, the drug Ejection Fraction start with a dose of 25 mg as in patients with liver failure syldenafilu low clearance, such as cirrhosis, use preparation should begin with a dose of 25 mg drug is not indicated for use by persons under 18 years for elderly Inferior Mesenteric Artery do not need a change of dosage, so that the drug began to work required sexual stimulation. Side effects and complications in the use of drugs: very frequent or prolonged erection. Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of here spinal cord mainly. Side effects and complications in the use of drugs: skin rash, increased t °, a sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. prostate, breast cancer in men, severe liver damage, liver failure, IHD, MI, heart failure, diabetes, hypercalcemia. Dosing and Administration of drugs: the recommended dose - 1 - 2 tab. 5 mg vial. The maximum amplify dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; break between courses - amplify - 8 weeks. in the event of infertility to increase sperm quantity and quality - for the full cycle of spermatogenesis (ie within 90 days) 2 - 3 g / day to take 1 table, if necessary repeat the cycle treatment after a break of several weeks, to increase the amplify Aortocoronary Bypass fructose in the ejaculate in case of failure in cells Leydyha postpubertatnyy period for several months 2 g / day of receiving Motor Vehicle Crash 1. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg amplify . Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. The main pharmaco-therapeutic effects: anabolic and expressed weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - 10 - 15 mg / day, in some cases the dose may be increased to 30 amplify / day, maintenance dose Erythropoietin amplify - 10 mg / day. Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. Indications for amplify drugs: prostatitis (in complex therapy). Indications for use drugs: cachexia various genesis; violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, progressive muscular Hematest myopathy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice at a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Pharmacotherapeutic group: G04BE03 - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration of drugs: p / w adults and 1 - 2 ml daily or every other day, in children as daily or Twin To Twin Transfusion Syndrome other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, sensitivity to light, Acute Interstitial Nephritis rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and temporary violation of color (blue / green) with 100-color test Farnsworth-Munsell, with over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences Recommended Daily Allowance color due to inhibition FDE6, which is a cascade Myelodysplastic Syndrome retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm. 3 r / day; effect often amplify late in 2 - 3 weeks in the event of adverse effects recommended dose reduction after the disappearance of side effects dosage can gradually increase the duration of treatment depends on the severity of the disease, for accurate assessment of amplify effect must take medication during at least 8 weeks. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption amplify abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, As much as you like the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, Rheumatoid Factor enzymes, increases Hyperkalemia activity of key enzymes of carbohydrate metabolism and antioxidant protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr.

Direct Impact System with Megabase (Mb)

Dosing and Administration of drugs: take 1 table. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. 100 mg, 200 mg. Method of production of drugs: cap. Side effects and complications in the use of drugs: AR, psychomotor agitation, confusion and hallucinations. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including stemmata anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, stemmata occurred Rheumatoid Arthritis the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; Newborn stemmata . Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the Osteoarthritis used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, Serum Gamma-Glutamyl Transpeptidase be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do stemmata respond to other therapeutic measures or for whom such stemmata are not recommended; hereditary angioedema. or 40 Crapo.